Stay updated on Psilocybin for Depression in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.

Latest updates to the Psilocybin for Depression in Early Alzheimer's Clinical Trial page
- Check5 days agoChange DetectedThe page revision/version indicator has been updated from **v3.5.2** to **v3.5.3**, reflecting a site/software update rather than any change to the trial information.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedAdded new Study Contact Backup details for Albert Garcia-Romeu, PhD and Ian Geithner, MPS (emails and phone numbers) and Johns Hopkins Center for Psychedelic and Consciousness Research; removed Hillary Jackson and related contact information.SummaryDifference2%

- Check48 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed. This update appears to be an internal version change and does not alter study content or functionality visible on the page.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.2 was introduced on the page. The Online study screener, Johns Hopkins University sponsor attribution, the Helpful Links Provided by section, and the previous Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check84 days agoChange DetectedThe page's revision metadata updated from v3.4.0 to v3.4.1 (v3.4.1 added, v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Psilocybin for Depression in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression in Early Alzheimer's Clinical Trial page.